Evolent Health (EVH) Short-term Investments (2016 - 2025)
Evolent Health (EVH) has 11 years of Short-term Investments data on record, last reported at $23.7 million in Q3 2025.
- For Q3 2025, Short-term Investments rose 44.95% year-over-year to $23.7 million; the TTM value through Sep 2025 reached $23.7 million, up 44.95%, while the annual FY2024 figure was $59.3 million, 330.67% up from the prior year.
- Short-term Investments reached $23.7 million in Q3 2025 per EVH's latest filing, down from $24.4 million in the prior quarter.
- Across five years, Short-term Investments topped out at $75.7 million in Q4 2021 and bottomed at $13.8 million in Q4 2023.
- Average Short-term Investments over 5 years is $33.4 million, with a median of $23.7 million recorded in 2025.
- Peak YoY movement for Short-term Investments: soared 426.54% in 2021, then plummeted 80.85% in 2022.
- A 5-year view of Short-term Investments shows it stood at $75.7 million in 2021, then tumbled by 80.85% to $14.5 million in 2022, then fell by 5.0% to $13.8 million in 2023, then skyrocketed by 330.67% to $59.3 million in 2024, then crashed by 60.05% to $23.7 million in 2025.
- Per Business Quant database, its latest 3 readings for Short-term Investments were $23.7 million in Q3 2025, $24.4 million in Q2 2025, and $16.2 million in Q1 2025.